Trovagene Announces Participation at The MicroCap Conference on October 1st and 2nd at the Essex House in New …
PR Newswire (press release) SAN DIEGO, Sept. 18, 2018 /PRNewswire/ — Trovagene, Inc. (NASDAQ : TROV), a clinical-stage oncology therapeutics company, developing targeted therapies for the treatment of leukemias, lymphomas and solid tumor cancers, today announced it will be … |
Source:: MicroCap Stock News From Google News